When you take pills or supplements orally, they need to go through your stomach and intestines, which can significantly reduce their effectiveness
Persistent or severe gastrointestinal symptoms while on GLP-1 therapy, such as severe nausea, vomiting, diarrhea, or severe abdominal pain, should prompt immediate medical evaluation
Appreciate your services
Lets tackle the most common Wegovy Zepbound myths debunked with clear evidence, focusing on the Wegovy Zepbound myths that cloud patient expectations and concerns
Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist specifically licensed for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities
Doctors AOM awareness, perception and decision-making will evolve rapidly, and tracking this closely will be an important first step to ensuring that doctors are aware of the benefits that new treatment options provide
